Clinical trial Recruiting at 1 site Interventional Ages 60 to 85

Effects of Theta Burst Stimulation on Pain and Cognition in Older Adults

Official title: The Effect of Intermittent Theta Burst Stimulation on Brain Characteristics, Pain Intensity, and Cognitive Functions in Older People with Chronic Musculoskeletal Pain: a Double-blinded, Randomized, Sham-controlled, Mixed-methods, Pilot Trial with a Six-month Post-treatment Follow-up.

Run by The Hong Kong Polytechnic University · NCT06709963 · Data updated 2026-11-12

This study is testing whether a new brain stimulation technique can help older adults with chronic pain feel better and think more clearly.

More Chronic Musculoskeletal Pain trials

Quick facts

Study typeInterventional
Ages60 Years to 85 Years
SexAll
Enrollment30 (estimated)
SponsorThe Hong Kong Polytechnic University
Academic / other
Locations1 site (Hong Kong)
StatusRecruiting
StartedSeptember 20, 2024
Main results expectedDecember 31, 2026
Study endsDecember 31, 2026
Registry record updatedJanuary 15, 2025
Trial IDNCT06709963 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are older adults with chronic nonspecific low back pain or chronic knee pain, who have normal cognitive function and meet specific educational and communication criteria.

Probably not a fit

Patients with specific causes of chronic pain or those unable to ambulate without assistance may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial investigates the impact of accelerated intermittent Theta Burst Stimulation (iTBS) on pain relief and cognitive function in older adults suffering from chronic musculoskeletal pain. Participants will receive a series of iTBS sessions over 14 days, and their brain activity will be monitored using MRI scans to understand the neurophysiological mechanisms involved. The study aims to determine the effectiveness of iTBS in alleviating pain and enhancing cognitive abilities in this demographic.

Why it matters

Potential benefit: If successful, this approach could significantly improve pain management and cognitive function in older adults with chronic musculoskeletal pain.

How similar studies have gone: While the use of iTBS is a relatively novel approach, preliminary studies have shown promise in similar applications, suggesting potential for success.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* have normal cognitive function (Hong Kong Montreal Cognitive Assessment ≥ 26)
* be right-handed
* be able to speak Cantonese
* chronic nonspecific low back pain, or having both chronic nonspecific low back pain and chronic knee pain that has lasted for at least 3 months
* an average pain intensity of ≥ 5 out of 10 on an 11-point numerical rating scale in the last 7 days, where 0 means "no pain" and 10 means "worst pain imaginable"
* having pain at least half of the days in the past 4 weeks.
* have at least 6 years of formal education and know how to read and write Chinese
* agree to sign an informed consent and complete the experiment tests
* be able to communicate via email or text message, as several study measures will be collected electronically

Exclusion Criteria:

* inability to ambulate without assistance from another person (canes or walkers will be allowed);
* having specific causes of chronic nonspecific low back pain, or having both chronic nonspecific low back pain and chronic knee pain (e.g., spinal stenosis, lumbar disc herniation, spondylolisthesis, recent vertebral fracture, spinal infection);
* having other concurrent musculoskeletal conditions at other body parts (e.g., fibromyalgia, or neck pain)
* self-reported history of lumbar or lower extremity surgery
* self-reported history of neurological or psychiatric disorders (e.g., stroke, brain surgery, head trauma; schizophrenia, multiple personality disorder, dissociative identity disorder, stroke) or self-reported cancer history
* self-reported specific inflammatory disorder: rheumatoid arthritis, rheumatica, scleroderma, lupus, or polymyositis
* unexplained, unintended weight loss of 20 lbs or more in the past year
* cauda equina syndrome
* uncorrected visual deficit
* drug or alcohol addiction
* taken alcohol, opioids or benzodiazepines medicines 24 hours before the experiment
* claustrophobia
* contraindications for undergoing the magnetic resonance imaging (MRI) examination based on the MRI safety screening form of University Research Facility in Behavioral and Systems Neuroscience (UBSN) at The Hong Kong Polytechnic University (PolyU)

Where it's running

  • The Hong Kong Polytechnic University
    Hong Kong, Hong Kong
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.